Comments
Cipla South Africa, a wholly-owned subsidiary of Cipla Limited, is to acquire 100 per cent of the issued shares of Actor Pharma (Pty) Limited (“Actor”) from Actor Holdings (Pty) Limited. Actor Pharma, founded in 2009, has grown to become the 5th largest privately owned OTC player in the South African private market.
Umang Vohra, Global MD & CEO of Cipla Limited, stated, “This is in line with our strategy of strengthening our OTC and wellness portfolio. We believe this is an excellent opportunity to leverage our existing marketing capabilities, unlock future growth opportunities, and optimize the performance of our pipeline”.
The shares were up by 1.34 per cent to Rs. 1255.50 on 9.43 a.m. on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.